NRG BR003 Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

June 29, 2018
https://clinicaltrials.gov/ct2/show/NCT02488967
Cancer - Breast
Principal Investigator: Thomas J Doyle, MD
CANCER, BREEAST, BREAST CANCER, TRIPLE NEGATIVE
Accepting Participants